GLP-1 receptor agonists are medications designed to mimic a natural hormone called glucagon-like peptide-1, which helps regulate blood sugar levels and appetite
These lawsuits assert legal theories, including: Trademark infringement Violating the corporate practice of medicine doctrine False advertising Unfair competition Violations of federal drug laws (misbranding, unapproved new drugs) FDA Enforcement On February 6, 2026, FDA announced its intent to use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns. The FDA explicitly announced steps to combat compounding pharmacies making these marketing claims: Compounded products are generic versions of FDA-approved drugs Compounded products are the same as FDA-approved drugs Compounded products use the same active ingredient as FDA-approved drugs Compounded products are clinically proven to produce results FDA has made clear that failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction. This means the agency may bypass traditional warning letter procedures
Every patient receives a pre-therapy clinical assessment and where indicated, advanced biomarker testing that identifies their specific biological ageing priorities
This eye disease used to affect the majority of people with diabetes given enough time , but modern interventions have reduced the risk considerably
Early research suggests that taking acetyl-L-carnitine reduces the need for pain medication in people with sciatica
